Table of Content

1. Executive Summary
1.1. Global Keloid Treatment Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Treatment Lifecycle Analysis
2.4. Global Keloid Treatment Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Keloid Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Keloid Treatment Market Outlook: Treatment
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Treatment, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment, 2023 - 2030
3.3.3.1. Occlusive Dressing
3.3.3.2. Compression Therapy
3.3.3.3. Cryosurgery
3.3.3.4. Excision
3.3.3.5. Radiation Therapy
3.3.3.6. Laser Therapy
3.3.3.7. Interferon Therapy
3.3.3.8. Intralesional Corticosteroid Injections
3.3.3.9. Others
3.4. Market Attractiveness Analysis: Treatment
3.5. Global Keloid Treatment Market Outlook: End User
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
3.5.3.1. Hospitals
3.5.3.2. Dermatology Clinics
3.5.3.3. Ambulatory Surgical Centers (ASCs)
3.5.3.4. Others
3.6. Market Attractiveness Analysis: End User
4. Global Keloid Treatment Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Global Keloid Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Treatment
5.3.3. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment, 2023 - 2030
5.5.1. Occlusive Dressing
5.5.2. Compression Therapy
5.5.3. Cryosurgery
5.5.4. Excision
5.5.5. Radiation Therapy
5.5.6. Laser Therapy
5.5.7. Interferon Therapy
5.5.8. Intralesional Corticosteroid Injections
5.5.9. Others
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
5.6.1. Hospitals
5.6.2. Dermatology Clinics
5.6.3. Ambulatory Surgical Centers (ASCs)
5.6.4. Others
5.7. Market Attractiveness Analysis
6. Europe Global Keloid Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Treatment
6.3.3. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Türkiye
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment, 2023 - 2030
6.5.1. Occlusive Dressing
6.5.2. Compression Therapy
6.5.3. Cryosurgery
6.5.4. Excision
6.5.5. Radiation Therapy
6.5.6. Laser Therapy
6.5.7. Interferon Therapy
6.5.8. Intralesional Corticosteroid Injections
6.5.9. Others
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
6.6.1. Hospitals
6.6.2. Dermatology Clinics
6.6.3. Ambulatory Surgical Centers (ASCs)
6.6.4. Others
6.7. Market Attractiveness Analysis
7. East Asia Global Keloid Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Treatment
7.3.3. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment, 2023 - 2030
7.5.1. Occlusive Dressing
7.5.2. Compression Therapy
7.5.3. Cryosurgery
7.5.4. Excision
7.5.5. Radiation Therapy
7.5.6. Laser Therapy
7.5.7. Interferon Therapy
7.5.8. Intralesional Corticosteroid Injections
7.5.9. Others
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
7.6.1. Hospitals
7.6.2. Dermatology Clinics
7.6.3. Ambulatory Surgical Centers (ASCs)
7.6.4. Others
7.7. Market Attractiveness Analysis
8. South Asia & Oceania Global Keloid Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Treatment
8.3.3. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment, 2023 - 2030
8.5.1. Occlusive Dressing
8.5.2. Compression Therapy
8.5.3. Cryosurgery
8.5.4. Excision
8.5.5. Radiation Therapy
8.5.6. Laser Therapy
8.5.7. Interferon Therapy
8.5.8. Intralesional Corticosteroid Injections
8.5.9. Others
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
8.6.1. Hospitals
8.6.2. Dermatology Clinics
8.6.3. Ambulatory Surgical Centers (ASCs)
8.6.4. Others
8.7. Market Attractiveness Analysis
9. Latin America Global Keloid Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Treatment
9.3.3. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment, 2023 - 2030
9.5.1. Occlusive Dressing
9.5.2. Compression Therapy
9.5.3. Cryosurgery
9.5.4. Excision
9.5.5. Radiation Therapy
9.5.6. Laser Therapy
9.5.7. Interferon Therapy
9.5.8. Intralesional Corticosteroid Injections
9.5.9. Others
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
9.6.1. Hospitals
9.6.2. Dermatology Clinics
9.6.3. Ambulatory Surgical Centers (ASCs)
9.6.4. Others
9.7. Market Attractiveness Analysis
10. Middle East & Africa Global Keloid Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Treatment
10.3.3. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment, 2023 - 2030
10.5.1. Occlusive Dressing
10.5.2. Compression Therapy
10.5.3. Cryosurgery
10.5.4. Excision
10.5.5. Radiation Therapy
10.5.6. Laser Therapy
10.5.7. Interferon Therapy
10.5.8. Intralesional Corticosteroid Injections
10.5.9. Others
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
10.6.1. Hospitals
10.6.2. Dermatology Clinics
10.6.3. Ambulatory Surgical Centers (ASCs)
10.6.4. Others
10.7. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Analog IC
11.2.3. Apparent Treatment Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Novartis AG
11.3.1.1. Overview
11.3.1.2. Segments and Treatment
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Sensus Healthcare
11.3.2.1. Overview
11.3.2.2. Segments and Treatment
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. RXi Pharmaceuticals, Inc.
11.3.3.1. Overview
11.3.3.2. Segments and Treatment
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Sonoma Pharmaceuticals, Inc.
11.3.4.1. Overview
11.3.4.2. Segments and Treatment
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Perrigo Company plc.
11.3.5.1. Overview
11.3.5.2. Segments and Treatment
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Bristol-Myers Squibb Company
11.3.6.1. Overview
11.3.6.2. Segments and Treatment
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Pacific World Corporation
11.3.7.1. Overview
11.3.7.2. Segments and Treatment
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Valeant Pharmaceuticals International, Inc.
11.3.8.1. Overview
11.3.8.2. Segments and Treatment
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. Revitol Corporation
11.3.9.1. Overview
11.3.9.2. Segments and Treatment
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. Avita Medical Limited
11.3.10.1. Overview
11.3.10.2. Segments and Treatment
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations